(TSX:ELD),(NYSE:EGO), VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) — Eldorado Gold Corporation (“Eldorado” or “the Company“) announces that the Toronto Stock Exchange (the “TSX“) has accepted the notice filed by the Company to amend its normal course issuer bid (the “NCIB“) effective as of May 6, 2025. The amendment increases the maximum number of […]
With the increasing prevalence of mental health conditions, especially within the schizophrenia and bipolar disorder populations, IGALMI holds strong market potential. The drug's unique sublingual formulation offers a rapid onset of action, which could position it as a valuable option in the behavioral health market. DelveInsight's 'IGALMI Market Size, Forecast, and Market Insight Report' highlights
Eldorado Gold Announces Amended Normal Course Issuer Bid GlobeNewswire May 01, 2025 VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) — Eldorado Gold Corporation (“Eldorado” or “the Company“) announces that the Toronto Stock Exchange (the “TSX“) has accepted the notice filed by the Company to amend its normal course issuer bid (the “NCIB“) effective as
(TSX-V:MAH),(Pinksheets:MKSEF),(PinkSheets:MKSEF), CALGARY, ALBERTA,, May 01, 2025 (GLOBE NEWSWIRE) — Marksmen Energy Inc. (“Marksmen” or the “Company“) announced today that its annual financial statements, accompanying management's discussion and analysis and related chief executive officer (“CEO“) and chief financial officer (“CFO“) certifications for the financial year ended December 31, 2024 (the “Annual Filings“), may not be filed
Marksmen Energy Inc. Announces Delay in Filing its 2024 Annual Financial Statements and Issuance of Promissory Note GlobeNewswire May 01, 2025 CALGARY, ALBERTA,, May 01, 2025 (GLOBE NEWSWIRE) — Marksmen Energy Inc. (“Marksmen” or the “Company“) announced today that its annual financial statements, accompanying management's discussion and analysis and related chief executive officer (“CEO“) and
Robert Half Inc. (NYSE: RHI) today announced that its Board of Directorshas approved a quarterly cash dividend of $0.59 per share on the company's common stock. The cash dividend is payable on June 13, 2025, to shareholders of record at the close of business on May 23, 2025. https://mma.prnewswire.com/media/2188927/Robert_Half_v2_Logo.jpg About Robert Half Robert Half is
SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., a global biotech focused on the research, development, and commercialization of treatments for cancer and disorders of the central nervous system (CNS), today announced the publication of its research in the journal, Nature Communications, detailing the discovery of PVTX-405, a best-in-class IKZF2 molecular glue
(NYSE:AVA), SPOKANE, Wash., May 01, 2025 (GLOBE NEWSWIRE) — Avista Corp.'s (NYSE: AVA) board of directors has declared a quarterly dividend of $0.49 per share on the company's common stock. The common stock dividend is payable June 13, 2025, to shareholders of record at the close of business on May 13, 2025. The declaration of
Avista Corp. Board Declares Common Stock Dividend GlobeNewswire May 01, 2025 SPOKANE, Wash., May 01, 2025 (GLOBE NEWSWIRE) — Avista Corp.'s (NYSE: AVA) board of directors has declared a quarterly dividend of $0.49 per share on the company's common stock. The common stock dividend is payable June 13, 2025, to shareholders of record at the
IBM's technology coupled with the EY organization's deep domain experience reimagines the role of artificial intelligence in the evolving tax compliance landscape IBM (NYSE: IBM) and the EY organization continue to build upon their multiyear alliance, today announcing the availability of EY.ai for tax, built with IBM watsonx. The alliance couples watsonx, IBM's portfolio of